BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22296175)

  • 21. Strategies for tissue and organ decellularization.
    Gilbert TW
    J Cell Biochem; 2012 Jul; 113(7):2217-22. PubMed ID: 22415903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autologous extracellular matrix scaffolds for tissue engineering.
    Lu H; Hoshiba T; Kawazoe N; Chen G
    Biomaterials; 2011 Apr; 32(10):2489-99. PubMed ID: 21211834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of partially demineralized osteoporotic cancellous bone matrix combined with human bone marrow stromal cells for tissue engineering: an in vitro and in vivo study.
    Liu G; Sun J; Li Y; Zhou H; Cui L; Liu W; Cao Y
    Calcif Tissue Int; 2008 Sep; 83(3):176-85. PubMed ID: 18704250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electrospun polyurethane scaffolds for proliferation and neuronal differentiation of human embryonic stem cells.
    Carlberg B; Axell MZ; Nannmark U; Liu J; Kuhn HG
    Biomed Mater; 2009 Aug; 4(4):045004. PubMed ID: 19567936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adult stem cells, scaffolds for in vivo and in vitro myocardial tissue engineering.
    Di Felice V; De Luca A; Serradifalco C; Di Marco P; Verin L; Motta A; Guercio A; Zummo G
    Ital J Anat Embryol; 2010; 115(1-2):65-9. PubMed ID: 21072992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review paper: critical issues in tissue engineering: biomaterials, cell sources, angiogenesis, and drug delivery systems.
    Naderi H; Matin MM; Bahrami AR
    J Biomater Appl; 2011 Nov; 26(4):383-417. PubMed ID: 21926148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MHC II gene knockout in tissue engineering may prevent immune rejection of transplants.
    Yang M; Liu L
    Med Hypotheses; 2008; 70(4):798-801. PubMed ID: 17904760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acellular cardiac extracellular matrix as a scaffold for tissue engineering: in vitro cell support, remodeling, and biocompatibility.
    Eitan Y; Sarig U; Dahan N; Machluf M
    Tissue Eng Part C Methods; 2010 Aug; 16(4):671-83. PubMed ID: 19780649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Scaffolds based bone tissue engineering: the role of chitosan.
    Costa-Pinto AR; Reis RL; Neves NM
    Tissue Eng Part B Rev; 2011 Oct; 17(5):331-47. PubMed ID: 21810029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decellularization of bovine corneas for tissue engineering applications.
    Ponce Márquez S; Martínez VS; McIntosh Ambrose W; Wang J; Gantxegui NG; Schein O; Elisseeff J
    Acta Biomater; 2009 Jul; 5(6):1839-47. PubMed ID: 19286434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Musculoskeletal tissue engineering by endogenous stem/progenitor cells.
    Nie H; Lee CH; Tan J; Lu C; Mendelson A; Chen M; Embree MC; Kong K; Shah B; Wang S; Cho S; Mao JJ
    Cell Tissue Res; 2012 Mar; 347(3):665-76. PubMed ID: 22382390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The kidney].
    Dubernard JM
    Bull Acad Natl Med; 2011 Oct; 195(7):1661-7. PubMed ID: 22812168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and testing of biological scaffolds for delivering reparative cells to target sites in the lung.
    Ingenito EP; Sen E; Tsai LW; Murthy S; Hoffman A
    J Tissue Eng Regen Med; 2010 Jun; 4(4):259-72. PubMed ID: 20020503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular therapy and myocardial tissue engineering: the role of adult stem and progenitor cells.
    Wu KH; Liu YL; Zhou B; Han ZC
    Eur J Cardiothorac Surg; 2006 Nov; 30(5):770-81. PubMed ID: 16963271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell-based therapies for lung disease.
    Garcia O; Carraro G; Navarro S; Bertoncello I; McQualter J; Driscoll B; Jesudason E; Warburton D
    Br Med Bull; 2012; 101(1):147-61. PubMed ID: 22279079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of heart valve leaflet matrix characteristics on the interaction between human mesenchymal stem cells and decellularized scaffolds.
    Iop L; Renier V; Naso F; Piccoli M; Bonetti A; Gandaglia A; Pozzobon M; Paolin A; Ortolani F; Marchini M; Spina M; De Coppi P; Sartore S; Gerosa G
    Biomaterials; 2009 Sep; 30(25):4104-16. PubMed ID: 19481252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CNS stem and progenitor cell differentiation into functional neuronal circuits in three-dimensional collagen gels.
    Ma W; Fitzgerald W; Liu QY; O'Shaughnessy TJ; Maric D; Lin HJ; Alkon DL; Barker JL
    Exp Neurol; 2004 Dec; 190(2):276-88. PubMed ID: 15530869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Matrix-mediated retention of adipogenic differentiation potential by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion.
    Mauney JR; Volloch V; Kaplan DL
    Biomaterials; 2005 Nov; 26(31):6167-75. PubMed ID: 15913765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prenatally harvested cells for cardiovascular tissue engineering: fabrication of autologous implants prior to birth.
    Weber B; Zeisberger SM; Hoerstrup SP
    Placenta; 2011 Oct; 32 Suppl 4():S316-9. PubMed ID: 21575988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Construction of tissue-engineered heart valves by using decellularized scaffolds and endothelial progenitor cells.
    Fang NT; Xie SZ; Wang SM; Gao HY; Wu CG; Pan LF
    Chin Med J (Engl); 2007 Apr; 120(8):696-702. PubMed ID: 17517187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.